Related Experiment Video
Updated: Mar 11, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
Expression and significances of MiRNA Let-7 and HMGA2 in laryngeal carcinoma
1Department of Otolaryngology Head and Neck Surgery, Tianjin Union Medical Center, Tianjin, China. yangyangtjin@163.com.
Objective:
High mobility group protein A2 (HMGA2) is a reported new oncogene been regulated by tumor suppressor microRNA Let-7. HMGA2 has become a hot topic in fundamental and clinical research of laryngeal carcinoma. The aim of the current study is to investigate the molecular mechanism of Let-7 and HMGA2 in oncogenesis and progression of laryngeal cancer.
Patients And Methods:
We used quantitative RT-PCR to detect the expression of miRNA Let-7a and HMGA2 mRNA from 59 pairs of fresh laryngeal cancer tissues and adjacent tissues collected for the laryngeal cancer patient. The expression of HMGA2 protein was detected by western blot method.
Results:
There is a negative correlation between low expressed miRNA Let-7a and high expression of HMGA2 mRNA in human laryngeal cancer (p < 0.05). The expressions of miRNA Let-7a and HMGA2 have a significant difference in patients with clinical stage I-II and clinical stage III-IV, patients with well-differentiated tumor and patients with poorly differentiated tumor, patients with lymph node metastasis and patients without lymph node metastasis. Spearman correlation analysis of miRNA Let-7a and HMGA2 mRNA showed expression of miRNA Let-7a is negatively correlated with HMGA2 expression.
Conclusions:
The down-regulation of miRNA Let-7a and up-regulation of HMGA2 promote the invasion and metastasis of laryngeal cancer.
Insights
Low levels of microRNA Let-7a and high levels of High-mobility group AT-hook 2 (HMGA2) protein correlate with advanced laryngeal cancer. This suggests HMGA2 is an oncogene promoted by Let-7a down-regulation, driving cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- High-mobility group protein A2 (HMGA2) is an oncogene implicated in laryngeal carcinoma.
- MicroRNA Let-7a acts as a tumor suppressor, regulating HMGA2 expression.
- The interplay between Let-7a and HMGA2 is crucial in laryngeal cancer development.
Purpose of the Study:
- To investigate the molecular mechanisms of Let-7a and HMGA2 in laryngeal cancer oncogenesis.
- To determine the correlation between Let-7a and HMGA2 expression in laryngeal tissues.
- To assess the role of Let-7a and HMGA2 in tumor progression and metastasis.
Main Methods:
- Quantitative RT-PCR was used to measure Let-7a miRNA and HMGA2 mRNA expression.
- Western blot analysis detected HMGA2 protein levels.
- Spearman correlation analysis assessed the relationship between Let-7a and HMGA2.
Main Results:
- A significant negative correlation was observed between Let-7a expression and HMGA2 expression (p < 0.05).
- Expression levels differed significantly across clinical stages, differentiation grades, and lymph node metastasis.
- Down-regulation of Let-7a and up-regulation of HMGA2 were associated with increased invasion and metastasis.
Conclusions:
- MicroRNA Let-7a acts as a tumor suppressor in laryngeal cancer by inhibiting HMGA2.
- The down-regulation of Let-7a and subsequent up-regulation of HMGA2 promote laryngeal cancer invasion and metastasis.
- Targeting the Let-7a/HMGA2 pathway may offer therapeutic strategies for laryngeal carcinoma.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

